Anti‐proliferative effects of pentagamaboronon‐0‐sorbitol on HER2‐overexpressing breast cancer cells
HER2‐positive breast cancer is an aggressive form of the disease that is associated with poor prognosis and chemo‐resistance. As such, investigation continues into the development of a new HER2‐targeted drug for breast cancer. This study investigated the anti‐proliferative activities of pentagamabor...
Main Authors: | Lailatul Qodria, Rohmad Yudi Utomo, Adam Hermawan, Edy Meiyanto |
---|---|
Format: | Article |
Language: | English |
Published: |
Universitas Gadjah Mada, Yogyakarta
2022-06-01
|
Series: | Indonesian Journal of Biotechnology |
Subjects: | |
Online Access: | https://jurnal.ugm.ac.id/ijbiotech/article/view/67549 |
Similar Items
-
Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application
by: Ratna Asmah Susidarti, et al.
Published: (2019-01-01) -
Anti‐proliferative effects of pentagamaboronon‐0‐sorbitol on HER2‐overexpressing breast cancer cells
by: Qodria, Lailatul, et al.
Published: (2022) -
Transcriptomics analyses reveal the effects of Pentagamaboronon-0-ol on PI3K/Akt and cell cycle of HER2+ breast cancer cells
by: Adam Hermawan, et al.
Published: (2023-12-01) -
SYNTHESIS AND CYTOTOXIC ACTIVITY OF 2,5-BIS(4-BORONIC ACID)BENZYLIDINE CYCLOPENTANONE ON HER2 OVEREXPRESSED-CANCER CELLS
by: Rohmad Yudi Utomo, et al.
Published: (2017-04-01) -
Anti-metastatic Activity of Curcumin Analog Pentagamaboronon-0-Sorbitol Against HER2-overexpressed MCF-7 Breast Cancer Cells
by: Lailatul Qodria, et al.
Published: (2018-10-01)